{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:54:10Z","timestamp":1791572050418,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":2345,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1124\/jpet.118.248120","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T17:40:22Z","timestamp":1528738822000},"page":"367-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor"],"prefix":"10.1016","volume":"366","author":[{"given":"Michelle G.","family":"Baladi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Gatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Mailman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle L.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence P.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Janowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.248120_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/sleep\/12.6.487","article-title":"Automobile accidents in patients with sleep disorders","volume":"12","author":"Aldrich","year":"1989","journal-title":"Sleep"},{"key":"10.1124\/jpet.118.248120_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00008877-199302000-00008","article-title":"The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds","volume":"4","author":"Baker","year":"1993","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.118.248120_bib3","first-page":"S19","article-title":"JZP-110, a dopamine norepinephrine reuptake inhibitor (DNRI), with robust wake-promoting effects and low abuse potential","volume":"80","author":"Baladi","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.118.248120_bib4","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1016\/j.drugalcdep.2016.08.054","article-title":"Evaluation of the effects of JZP-110 in nonclinical models of abuse liability","volume":"171","author":"Baladi","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1124\/jpet.118.248120_bib5","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0278-5846(88)90014-0","article-title":"Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil","volume":"12","author":"Bastuji","year":"1988","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/jpet.118.248120_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2007.10.013","article-title":"Noradrenergic modulation of arousal","volume":"58","author":"Berridge","year":"2008","journal-title":"Brain Res Rev"},{"key":"10.1124\/jpet.118.248120_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","article-title":"The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes","volume":"42","author":"Berridge","year":"2003","journal-title":"Brain Res Rev"},{"key":"10.1124\/jpet.118.248120_bib8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/sleep\/33.10.1295","article-title":"Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy","volume":"33","author":"Burgess","year":"2010","journal-title":"Sleep"},{"key":"10.1124\/jpet.118.248120_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dta.1333","article-title":"Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model","volume":"4","author":"Canal","year":"2012","journal-title":"Drug Test Anal"},{"key":"10.1124\/jpet.118.248120_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/ml1002025","article-title":"Structure-activity relationships at the monoamine transporters for a novel series of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) analogues","volume":"2","author":"Cao","year":"2011","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/jpet.118.248120_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1615\/CritRevNeurobiol.v16.i12.130","article-title":"Dopamine reuptake by norepinephrine neurons: exception or rule?","volume":"16","author":"Carboni","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"10.1124\/jpet.118.248120_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s002130050182","article-title":"Acquisition of i.v. amphetamine and cocaine self-administration in rats as a function of dose","volume":"129","author":"Carroll","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.248120_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jsmc.2016.05.005","article-title":"Residual daytime sleepiness in obstructive sleep apnea after continuous positive airway pressure optimization: causes and management","volume":"11","author":"Chapman","year":"2016","journal-title":"Sleep Med Clin"},{"key":"10.1124\/jpet.118.248120_bib14","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.118.248120_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1476-5381.1963.tb01302.x","article-title":"A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine","volume":"20","author":"Corne","year":"1963","journal-title":"Br J Pharmacol Chemother"},{"key":"10.1124\/jpet.118.248120_bib16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(13)70225-4","article-title":"Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial","volume":"12","author":"Dauvilliers","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.118.248120_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.tpj.6500088","article-title":"Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil","volume":"2","author":"Dauvilliers","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/jpet.118.248120_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.smrv.2014.10.006","article-title":"Catechol-O-methyltransferase, dopamine, and sleep-wake regulation","volume":"22","author":"Dauvilliers","year":"2015","journal-title":"Sleep Med Rev"},{"key":"10.1124\/jpet.118.248120_bib19","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s40265-013-0127-y","article-title":"Current and emerging options for the drug treatment of narcolepsy","volume":"73","author":"De la Herr\u00e1n-Arita","year":"2013","journal-title":"Drugs"},{"key":"10.1124\/jpet.118.248120_bib20","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1097\/00001756-200111160-00032","article-title":"Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats","volume":"12","author":"de Saint Hilaire","year":"2001","journal-title":"Neuroreport"},{"key":"10.1124\/jpet.118.248120_bib21","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3565(24)38214-X","article-title":"Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type","volume":"289","author":"Eshleman","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib22","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","article-title":"Substituted methcathinones differ in transporter and receptor interactions","volume":"85","author":"Eshleman","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.118.248120_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jsr.12039","article-title":"Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure","volume":"22","author":"Gasa","year":"2013","journal-title":"J Sleep Res"},{"key":"10.1124\/jpet.118.248120_bib24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1164\/rccm.200605-629PP","article-title":"Sleep apnea, alertness, and motor vehicle crashes","volume":"176","author":"George","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.118.248120_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/jpet.113.206623","article-title":"N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement","volume":"347","author":"Gregory","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib26","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.118.248120_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/jpet.118.248120_bib28","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/npp.2009.3","article-title":"How to keep the brain awake? The complex molecular pharmacogenetics of wake promotion","volume":"34","author":"Hasan","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.118.248120_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0006-8993(80)90475-8","article-title":"Synthesis of catecholamines from [3H]tyrosine in brain during the performance of operant behavior","volume":"183","author":"Heffner","year":"1980","journal-title":"Brain Res"},{"key":"10.1124\/jpet.118.248120_bib30","first-page":"Unit7.9","article-title":"Uptake and release of neurotransmitters","volume":"Chapter 7","author":"Janowsky","year":"2001","journal-title":"Curr Protoc Neurosci"},{"key":"10.1124\/jpet.118.248120_bib31","series-title":"Principles and Practice of Sleep Medicine","first-page":"134","article-title":"Basic mechanisms of sleep\u2013wake states","author":"Jones","year":"2000"},{"key":"10.1124\/jpet.118.248120_bib32","first-page":"166","article-title":"The role of monoamines and acetylcholine-containing neurons in the regulation of the sleep-waking cycle","volume":"64","author":"Jouvet","year":"1972","journal-title":"Ergeb Physiol"},{"key":"10.1124\/jpet.118.248120_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0022-3565(25)12606-2","article-title":"Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys","volume":"254","author":"Kleven","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5664\/jcsm.4554","article-title":"Quality measures for the care of patients with narcolepsy","volume":"11","author":"Krahn","year":"2015","journal-title":"J Clin Sleep Med"},{"key":"10.1124\/jpet.118.248120_bib35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3565(24)37594-9","article-title":"Homologous desensitization of the D1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency","volume":"286","author":"Lewis","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.110.170134","article-title":"Histamine H3 receptors and sleep-wake regulation","volume":"336","author":"Lin","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","article-title":"R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse","volume":"72","author":"Loland","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1124\/jpet.118.248120_bib38","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0022-3565(24)39297-3","article-title":"Cloning of rat histamine H(3) receptor reveals distinct species pharmacological profiles","volume":"293","author":"Lovenberg","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro","volume":"319","author":"Madras","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib40","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.bmcl.2004.06.032","article-title":"Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX(2)R) antagonists","volume":"14","author":"McAtee","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.118.248120_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/sleep\/28.6.754","article-title":"Emerging therapies in narcolepsy-cataplexy","volume":"28","author":"Mignot","year":"2005","journal-title":"Sleep"},{"key":"10.1124\/jpet.118.248120_bib42","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"17","author":"Mignot","year":"1994","journal-title":"Sleep"},{"key":"10.1124\/jpet.118.248120_bib43","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"key":"10.1124\/jpet.118.248120_bib44","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3565(25)10762-3","article-title":"Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist","volume":"262","author":"Mottola","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib45","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1124\/jpet.301.3.1166","article-title":"Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase","volume":"301","author":"Mottola","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bbr.2006.10.016","article-title":"Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats","volume":"176","author":"Murillo-Rodr\u00edguez","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1124\/jpet.118.248120_bib47","first-page":"49","article-title":"Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants","volume":"1","author":"Nishino","year":"1998","journal-title":"Sleep Res Online"},{"key":"10.1124\/jpet.118.248120_bib48","doi-asserted-by":"crossref","first-page":"572","DOI":"10.5664\/jcsm.27352","article-title":"Health-related quality of life among drug-na\u00efve patients with narcolepsy with cataplexy, narcolepsy without cataplexy, and idiopathic hypersomnia without long sleep time","volume":"4","author":"Ozaki","year":"2008","journal-title":"J Clin Sleep Med"},{"key":"10.1124\/jpet.118.248120_bib49","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1124\/jpet.118.248120_bib50","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1183\/09031936.00016808","article-title":"Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study","volume":"33","author":"P\u00e9pin","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.118.248120_bib51","doi-asserted-by":"crossref","first-page":"8462","DOI":"10.1523\/JNEUROSCI.1819-08.2008","article-title":"Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil","volume":"28","author":"Qu","year":"2008","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.118.248120_bib52","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1007\/s00213-015-4065-0","article-title":"Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats","volume":"232","author":"Quisenberry","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.248120_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1124\/jpet.118.248120_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.sleep.2017.03.025","article-title":"Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes","volume":"35","author":"Ruoff","year":"2017","journal-title":"Sleep Med"},{"key":"10.1124\/jpet.118.248120_bib55","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.5665\/sleep.5968","article-title":"Effect of oral JZP-110 (ADX-N05) on wakefulness and sleepiness in adults with narcolepsy: a phase 2b study","volume":"39","author":"Ruoff","year":"2016","journal-title":"Sleep"},{"key":"10.1124\/jpet.118.248120_bib56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/157015908785777229","article-title":"Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation","volume":"6","author":"Samuels","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/jpet.118.248120_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.248120_bib58","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00002826-200309000-00009","article-title":"Dosing regimen effects of modafinil for improving daytime wakefulness in patients with narcolepsy","volume":"26","author":"Schwartz","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1124\/jpet.118.248120_bib59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-006-0483-3","article-title":"Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2","volume":"188","author":"Seneca","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.248120_bib60","series-title":"Principles and Practice of Sleep Medicine","first-page":"112","article-title":"Brainstem mechanisms generating REM sleep","author":"Siegel","year":"2000"},{"key":"10.1124\/jpet.118.248120_bib61","first-page":"608","article-title":"Excessive daytime sleepiness in sleep disorders","volume":"4","author":"Slater","year":"2012","journal-title":"J Thorac Dis"},{"key":"10.1124\/jpet.118.248120_bib62","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3565(25)12081-8","article-title":"Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys","volume":"275","author":"Spealman","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.248120_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(82)90685-0","article-title":"Dopaminergic substrates of amphetamine-induced place preference conditioning","volume":"253","author":"Spyraki","year":"1982","journal-title":"Brain Res"},{"key":"10.1124\/jpet.118.248120_bib64","series-title":"Brainstem Control of Wakefulness and Sleep","author":"Steriade","year":"1990"},{"key":"10.1124\/jpet.118.248120_bib65","doi-asserted-by":"crossref","first-page":"A1062","DOI":"10.1016\/j.chest.2017.08.1097","article-title":"Results of a randomized, placebo-controlled, double-blind, 12-week, multicenter study of solriamfetol (JZP-110) for the treatment of excessive sleepiness in patients with OSA","volume":"152","author":"Strohl","year":"2017","journal-title":"Chest"},{"key":"10.1124\/jpet.118.248120_bib66","doi-asserted-by":"crossref","first-page":"A1092","DOI":"10.1016\/j.chest.2017.08.1126","article-title":"Treatment of excessive sleepiness in patients with obstructive sleep apnea: efficacy and safety results of a 6-week, double-blind, placebo-controlled, randomized-withdrawal trial of solriamfetol (JZP-110)","volume":"152","author":"Strollo","year":"2017","journal-title":"Chest"},{"key":"10.1124\/jpet.118.248120_bib67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/syn.10120","article-title":"Food restriction modulates amphetamine-conditioned place preference and nucleus accumbens dopamine release in the rat","volume":"46","author":"Stuber","year":"2002","journal-title":"Synapse"},{"key":"10.1124\/jpet.118.248120_bib68","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/0269881113490326","article-title":"Functional neuroanatomy of the central noradrenergic system","volume":"27","author":"Szabadi","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.118.248120_bib69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2014.10.002","article-title":"Clinical and practical considerations in the pharmacologic management of narcolepsy","volume":"16","author":"Thorpy","year":"2015","journal-title":"Sleep Med"},{"key":"10.1124\/jpet.118.248120_bib70","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/j.sleep.2017.11.961","article-title":"A randomized, placebo-controlled, phase 3 study of the safety and efficacy of solriamfetol (JZP-110) for the treatment of excessive sleepiness in patients with narcolepsy","volume":"40","author":"Thorpy","year":"2017","journal-title":"Sleep Med"},{"key":"10.1124\/jpet.118.248120_bib71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410430115","article-title":"Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy","volume":"43","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.118.248120_bib72","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.54.5.1166","article-title":"Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy","volume":"54","year":"2000","journal-title":"Neurology"},{"key":"10.1124\/jpet.118.248120_bib73","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/sleep\/29.8.1036","article-title":"Medical therapy for obstructive sleep apnea: a review by the Medical Therapy for Obstructive Sleep Apnea Task Force of the Standards of Practice Committee of the American Academy of Sleep Medicine","volume":"29","author":"Veasey","year":"2006","journal-title":"Sleep"},{"key":"10.1124\/jpet.118.248120_bib74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/taap.1996.0161","article-title":"Triadimefon and triadimenol: effects on monoamine uptake and release","volume":"139","author":"Walker","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.118.248120_bib75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.smrv.2006.08.001","article-title":"Continuous positive airway pressure treatment for sleep apnea in older adults","volume":"11","author":"Weaver","year":"2007","journal-title":"Sleep Med Rev"},{"key":"10.1124\/jpet.118.248120_bib76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fneur.2013.00139","article-title":"Modafinil as a catecholaminergic agent: empirical evidence and unanswered questions","volume":"4","author":"Wisor","year":"2013","journal-title":"Front Neurol"},{"key":"10.1124\/jpet.118.248120_bib77","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.118.248120_bib78","doi-asserted-by":"crossref","first-page":"10060","DOI":"10.1523\/JNEUROSCI.0857-07.2007","article-title":"Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model","volume":"27","author":"Zhu","year":"2007","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.118.248120_bib79","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.108.146142","article-title":"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil","volume":"329","author":"Zolkowska","year":"2009","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524262261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524262261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.248120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:00:05Z","timestamp":1739995205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524262261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0022356524262261"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.248120","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.248120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"U.S. Government work not protected by U.S. copyright","name":"copyright","label":"Copyright"}]}}